Biofrontera Inc. (NASDAQ:BFRI) Short Interest Up 116.9% in November

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 686,600 shares, a growth of 116.9% from the November 15th total of 316,600 shares. Currently, 12.1% of the company’s shares are sold short. Based on an average trading volume of 2,820,000 shares, the days-to-cover ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

Separately, Benchmark reiterated a “buy” rating and issued a $7.00 price objective on shares of Biofrontera in a research report on Friday, November 15th.

Biofrontera Price Performance

Shares of BFRI remained flat at $1.06 on Friday. 507,480 shares of the company were exchanged, compared to its average volume of 1,046,629. The stock’s 50 day simple moving average is $0.91 and its 200 day simple moving average is $1.04. Biofrontera has a twelve month low of $0.61 and a twelve month high of $4.00. The stock has a market cap of $8.22 million, a PE ratio of -0.47 and a beta of 0.38.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.